The use of a drug marker in a clinical trial.
D002747:Chlorpropamide / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005452:Fluoresceins; D006801:Humans; D010919:Placebos; D012964:Sodium; D019966:Substance-Related Disorders / Q000175:diagnosis*
D005452:Fluoresceins; D010919:Placebos; D012964:Sodium; D002747:Chlorpropamide